Body Composition in Crohn’s Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration

Table 1

Baseline characteristics of patients of ulcerative colitis and Crohn’s disease.

	UC	CD	value
Parameters
Age in years, mean ± SD	33.2 ± 11.2	41.2 ± 15.8	0.01
Sex, male (, %)	36 (67.9%)	32 (72.7%)	0.61
Duration of symptoms (months), median	24 (12–48)	36 (18–105)	0.15
Haemoglobin, g/dL, mean ± SD	11.8 ± 2.5	10.8 ± 2.9	0.02
Albumin, g/dL, mean ± SD	4.2 ± 0.5	4.0 ± 0.8	0.11
Extent/location of disease	E1: 3 (5.6%); E2: 35 (66%); E3: 15 (28.3%)	L1: 21 (47.7%)
		L2: 10 (22.7%)
		L3: 11 (25%)
		L4: 10 (22.7%)
Disease behavior		B1: 21 (45.7%)
		B2: 23 (50%)
		B3: 2 (4.3%)
Treatment received
5-ASA	53 (100)	10 (22.7)
Steroids	16 (30.2)	29 (65.9)
Immunomodulators	17 (32.1)	26 (40.9)
Biologics	0 (0)	0 (0)

E1: proctitis; E2: left sided colitis; E3: pancolitis; L1: terminal ileum ± caecum; L2: colonic; L3: ileocolonic; L4: proximal small intestine; B1: inflammatory; B2: stricturing; B3: penetrating; p: perianal; ASA: aminosalicylic acid.